SCHEMBL7780485

SCHEMBL7780485

Cn1nc(-c2ccncc2)c(-c2ccc(S(N)(=O)=O)cc2)c1C(F)(F)F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.58
PTGS1 P23219 4/20 0.58
MAPK14 Q16539 2/20 0.51
LRRK2 Q5S007 2/20 0.45
KIF11 P52732 1/20 0.44
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CYP2C9 P11712 2/20 0.43
SRC P12931 1/20 0.43
BRAF P15056 1/20 0.43
KDR P35968 1/20 0.43
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
ALOX5 P09917 2/20 0.42
PDPK1 O15530 2/20 0.42
PTGES O14684 1/20 0.42
HDAC3 O15379 1/20 0.42
PDE5A O76074 1/20 0.42
ABCB11 O95342 1/20 0.42
MT-CO2 P00403 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780120 0.89 PTGS2 (0.58) PTGS2PTGS1MAPK14ALOX5
SCHEMBL7780051 0.89 PTGS2 (0.60) PTGS2PTGS1CA1CA2CA12
SCHEMBL7780017 0.89 PTGS2 (0.73) PTGS2PTGS1MAPK14CA1CA2
SCHEMBL7778026 0.89 PTGS2 (0.58) PTGS2PTGS1MAPK14ALOX5
SCHEMBL7780799 0.89 PTGS2 (0.60) PTGS2PTGS1MAPK14CA1CA2
SCHEMBL7779998 0.88 PTGS2 (0.58) PTGS2PTGS1CA1CA2CA12
SCHEMBL7779784 0.86 PTGS2 (0.56) PTGS2PTGS1MAPK14KIF11CA1
SCHEMBL7779604 0.86 PTGS2 (0.56) PTGS2PTGS1CA1CA2CA12
SCHEMBL6302333 0.85 PTGS2 (0.81) PTGS2PTGS1LRRK2KIF11CA1
SCHEMBL7777556 0.85 PTGS2 (0.81) PTGS2PTGS1LRRK2KIF11CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed